PALLADIA

Product Overview

About PALLADIA

PALLADIA is a medicine that contains the active ingredient TOCERANIB (TOCERANIB PHOSPHATE), which is used to treat certain types of cancer in animals. It is a tyrosine kinase inhibitor that works by blocking specific enzymes involved in the growth and spread of cancer cells. PALLADIA is specifically designed to target and inhibit the activity of these enzymes, helping to slow down the progression of the disease.

Key Benefits & Uses

• Treatment of mast cell tumors in dogs
• Reduction of tumor size and improvement of clinical symptoms
• Delaying the progression of the disease and improving quality of life

Active Ingredient & Action

TOCERANIB (TOCERANIB PHOSPHATE) is the active ingredient in PALLADIA, which works by inhibiting the activity of tyrosine kinases, including KIT, FLT3, and VEGFR. This inhibition leads to a reduction in the growth and spread of cancer cells, ultimately resulting in a decrease in tumor size and an improvement in clinical symptoms.

Important Notes

It is essential to use PALLADIA under the guidance of a veterinarian, as it can have potential side effects. Regular monitoring of the animal's health and adjustment of the dosage as needed is crucial to ensure the safe and effective use of the medicine. Additionally, it is important to follow the recommended dosage and administration instructions to minimize the risk of adverse reactions.